Veterinary Medication Market Report: Trends, Forecast and Competitive Analysis to 2030

Veterinary Medication Trends and Forecast

The future of the global veterinary medication market looks promising with opportunities in the veterinary hospital pharmacy and retail veterinary pharmacy markets. The global veterinary medication market is expected to reach an estimated $62.2 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing number of pet ownership, increasing global livestock population, and rising risk of chronic diseases among animals.

• Lucintel forecasts that, within the route of administration category, parenteral will remain the largest segment due to its easy availability and quick onset of action.

• Within the distribution channel category, veterinary hospital pharmacy is expected to witness a higher growth over the forecast period.

• In terms of regions, North America is expected to witness the highest growth over the forecast period. Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Veterinary Medication Market

Several emerging trends can be observed within the veterinary medication market which are as a result of improved technologies, increased attention to animal health, and patient-oriented changes.

• Targeted Therapy: Therapies for animals are becoming individualized thanks to genomic and diagnostic innovations. The approach is particularly aimed at improving the efficacy of clinical cases by availing treatments determined by genetic and health profiles. This is important when dealing with chronic diseases and improving the health and wellness of the patients.

• The Application of Information Technologies: Telemedicine, artificial intelligence, and other contemporary technologies are already changing the practice of veterinary medicine. Communication with a patient using online platforms allows for remote visits, while online staff can monitor the progress and take actions based on data. These devices eliminate the problem of inaccessibility of health services, expediting the whole diagnosis process and enhancing the treatment of pets as well as veterinarians.

• Concentration on Antimicrobial Prescribing Patterns: There is a particular concern to enhance antibiotics resistance that translates into detailed dissemination of structures and measures that should be enforced prescriptions. This includes the baring from over reliance on existing medications by coming up with new classes of antimicrobials. This trend is important for the future use of antibiotics and allows for the effective treatment of bacterial infections on animals.

• Biologics and Vaccines Progress: Biologics and vaccine developments are contributing positively to innovation in veterinary medicine. Novel vaccines and biologics is enhancing the animal health by providing better protection against infections. This trend also encompasses the research for the vaccines related to new infections and making vaccines for individuals in correspondence to their genes.

• Sustainability and Green Chemistry: Sustainability is gaining importance in veterinary medicine through the research of the eco-centric developments of the dosage forms and its production. Green Chemistry is one of the approaches considered in the reduction of the environmental hazards caused by the deposition of veterinary pharmaceutical substances. This trend is in accordance with the sustainability targets all over the world as well as the demand for consumers from the manufacturers on the association of product with environmental pollution. These trends are transforming the landscape of veterinary medication by expanding the opportunities for treatment, advancing the quality of care, and mitigating the new issues in animal health.

Recent Developments in the Veterinary Medication Market

In recent years, improvement in the area of patient medication among the veterinarians has been changing due to improved drug composition, improvement in regulations, and advance technologies.

• Emergence of Personalized Treatments: There is a change in treatment protocols due to the attainment of personalized veterinary medicine. The developments in genomic and diagnostic technologies enable physicians to prescribe therapies that cater to specific animal profiles. This in turn improves on the effectiveness of treatment and minimizes the side effects especially when treating diseases which are chronic and complex.

• Expansion of Biologics and Advanced Vaccines: These include biologics as well as advanced vaccines which are on the rise but bring along the more efficient treatments and better prevention of diseases. These innovations involve the use of different kinds of vaccines and biologics that treat particular diseases and organisms, thus enhancing animal health and disease control.

• Enhanced Regulatory Standards: Standards and regulations for veterinary medicines are becoming more stringent which in turn makes such products much safer and more effective. For example, there have been amendments in that they have made the approval process of new drugs more tedious, with a lot of testing being done. Such regulations help to increase the safety and quality of the medicines developed, thus supplying healthy products for both animals and people.

• Integration of Digital Health Solutions: The trend of incorporating innovations such as telemedicine and AI diagnostics has also been seen in the field of veterinary medicine. These technologies support off-site evaluation, continuous follow-up, and analysis of data, thereby improving the precision and follow-up care as well as the availability of veterinary clinics.

• Focus on Antimicrobial Resistance: The problem of antimicrobial resistance is well known in the area of medicating animals. This includes the creation of new antimicrobials and proper usage controls. This development is something which is very important in the proper control of infections in livestock and pets as well as fighting the increasing problem of resistance. These developments are improving the veterinary medicine by providing more and better treatment alternatives, efficient provision of care and meeting new health issues.

Strategic Growth Opportunities for Veterinary Medication Market

Several opportunities for growth can be found in the veterinary medication sector as influenced by technology and market change.

• Growing Demand for Pet Health Care: The increasing pet healthcare market is an attractive opportunity for the growth of veterinary medication. Increased pet ownership and a tendency towards wellness of pets cause an upsurge in the use of therapeutic and preventive measures. There is a need to develop new products which are intended for pets since the market is growing.

• Improved Livestock Health: Because of better livestock health, there are emerging opportunities for companies dealing with veterinary medication. The emergence of new vaccines, anti-parasitic agents and disease management systems solves problems associated with livestock farming. Enhancement of livestock health through research and development will also help to increase the yields of agricultural activities.

• Development of Precision Medicine: For veterinarians, developing and implementing precision medicine implies the corresponding targeted treatment and individual therapy. Treatment can also be more effective and clusters can show better results with usage of genetic data and other diagnostic data during the treatment. This trend is favorable to introduction of newer and better products in veterinary medicine.

• Technological Integration: Incorporating emerging technologies into veterinary medicine, such as telemedicine or artificial intelligence, presents an opportunity for growth. These technologies help improve diagnostic efficiencies, reduce the burden of care delivery, and increase low and middle income patients’ access to care. The ability to create products that leverage digital health marketing will capture changing consumer demand while also enhancing the market.

• Focus on Sustainability: The growing attention towards sustainability in veterinary medicine presents new growth opportunities. Developing sustainable and environmentally friendly product formulations and going green with drug manufacture leaves no adverse effects to the nature or the consumers. Continued investments in ensuring sustainability practices will help create better positioning of products in the market and maintain consistent growth. These growth opportunities span growth in current markets and the emergence of new, illustrating branded veterinary medication markets of the future, taking into account the convergence of evolving needs, technology, and branding opportunities.

Veterinary Medication Market Driver and Challenges

The market for veterinary medication exists, discuss the key drivers and challenges of this market, including, but not limited to, technology, regulations, and the economy. Those features play a role in the growth and development of market affecting the future of veterinary medicine and medication. The factors responsible for driving the veterinary medication market include:

• Technological Advancements: Technological progress helps the growth of the market of veterinary medicine owing to new treatments and diagnosis methods that surface. Emerging trends such as targeted therapies, improved methods of drug delivery and other digitalized healthcare strategies are expected to improve treatment outcomes and delivery of care. All these advancements promote the expansion of the market by enhancing better health to animals and increasing more available treatments.

• Pet Owners Growing as the Need for Healthy Pets Increases: Pet parents continue to skyrocket while an interest in the health of their pets pushes for better-quality veterinary medicines. Pet owners want more effective treatment for their pets which has led to development of new drug formulations and treatment approaches. This trend bolsters the market growth plus stimulates investments in R&D.

• Adherence to Regulations: Regulatory adherence is one of the factors driving the veterinary medicine market in terms of product development and approval. Tighter regulatory requirements help protect the safety and effectiveness of veterinary products thus enhancing the quality of drugs and the ability to market them. Adhering to such conditions is crucial in gaining trust and remaining competitive in the market.

• Emphasis on Antimicrobial Stewardship: The focus on antimicrobial stewardship fuels new antimicrobial agent development and new practice use. The issue of antimicrobial resistance must be addressed in order to retain proper control of more curing therapies as well as infiltration itself. This trend also facilitates new drug synthesis mechanisms and other inventions that promote the optimal use of already available medications.

• Market Dynamics: Economic factors are among the costs of materials and costs of production impacting the veterinary medication markets. Increased expenditure leads to depletion of margins and affordable prices which forces manufacturers to enhance their operational efficiencies and seek cheaper options. Conditions in the economy also determines the level of investment in new technologies and expansion of the market. Challenges in the veterinary medication market are:

• Regulatory Challenges: Regulatory risks are considerable barriers to entry to the veterinary medication market. To comply with laws regarding drug efficacy and safety, marketing restrictions, the environmental impacts of drugs, etc, a lot of time and resources must be spent. Such constraint can also affect efficiency of operations and entry into the market which warrants the need for total compliance with regulations.

• Economic Fluctuations: Economic fluctuations also impact on the veterinary medication market through the costs of obtaining raw materials and the general market stability. Change in the economy can also cause an increase in costs of production and changes in the focus of the company in investment in innovation and development of new products. Factors such as economic changes require that manufacturers relocate and reorganize their supply chains and manufacturing programs.

• Supply Chain Disruptions: Availability and costs of the raw material needed for the production of veterinary medication can be adversely affected by supply chain interruptions. Production coordination and costs may be susceptible to the international and regional supply chain complications including non-availability of the parts or delays in the supply of the same. The ability to mitigate and manage risk in the supply chain as well as acquisition of different suppliers is vital for stabilization of the market and availability of the product. The market for veterinary medications has been influenced not only by the common forces as presented above but also by the interlocking forces of drivers and barriers. The drivers of change include technological growth, an ever-growing need for pet healthcare and compliance to regulations while the barriers include regulatory barriers, macroeconomic issues, and supply chain constraints. These issues must be dealt with effectively and efficiently if growth in the market and expansion of veterinary services is to take place.

List of Veterinary Medication Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies veterinary medication companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the veterinary medication companies profiled in this report include-

• Virbac

• Merck

• Archer Daniels Midland

• Dechra Pharmaceuticals

• Ceva Santé Animale

• Boehringer Ingelheim

• Soparfin

• Elanco Animal Health

• Evonik Industries AG

• Zoetis

Veterinary Medication by Segment

The study includes a forecast for the global veterinary medication by product, route of administration, distribution channel, animal type, and region.

Veterinary Medication Market by Product [Analysis by Value from 2018 to 2030]:

• Drugs

• Vaccines

• Medicated Feed Additives

Veterinary Medication Market by Route of Administration [Analysis by Value from 2018 to 2030]:

• Oral Route

• Parenteral Route

• Topical Route

Veterinary Medication Market by Distribution Channel [Analysis by Value from 2018 to 2030]:

• Veterinary Hospitals Pharmacies

• Retail Veterinary Pharmacies

Veterinary Medication Market by Animal Type [Analysis by Value from 2018 to 2030]:

• Companion Animals

• Livestock Animals

Veterinary Medication Market by Region [Analysis by Value from 2018 to 2030]:

• North America

• Europe

• Asia Pacific

• The Rest of the World

Country Wise Outlook for the Veterinary Medication Market

The veterinary medicine industry is going through tumultuous changes due to various technological improvements, increasing consideration of the well-being of animals, and changing regulations. These trends include improvement in the quality of drugs developed, expansion of markets, and enhancement of treatment methods in different regions.

• United States: The last years in America concerning veterinary medicine have witnessed new veterinary drugs aimed at treating chronic diseases in pets and the development of new biologics including vaccines and gene therapies. Animals are becoming the new clients in the world of personalized medicine. Genomics is being used to develop treatments for individual pets rather than drugs for all pets. The environment is also changing with a more stringent approach to the use of antimicrobial drug by the FDA aimed at reducing their use and therefore resistance.

• China: The market for Veterinary medications in China is rapidly expanding because more people are keeping pets and livestock is produced on an industrial scale. Other recent responses have been new vaccines and antimicrobials to counter local diseases. The Governments of China and other countries have been tightening up the policies regarding the control of the safety and efficacy of drug products and there are moves to use more cutting edge technologies to enhance drug discovery and testing.

• Germany: It is quite clear that Germany has made great strides in veterinary medicine as it involves itself in more of new treatment options while satisfying regulatory requirements. Current activities include the launching of new drug formulations as well as biologics. As such, regulatory guarantees of the German government are working towards enhancing the safety and effectiveness of drugs. In addition, there is a strong movement towards improvement of veterinary care by incorporating telemedicine and other digital technologies.

• India: The Indian context also has to address the growing affordability and availability of veterinary medication services. Current activities include the goal to implement the broader vaccination strategies and the gold drench medicine program. There are also focused efforts on establishing domestic manufacturing capabilities in order to lessen the reliance on foreign sourcing and improve the supply chain performance.

• Japan: Such guidelines have removed bureaucratic interference from the veterinary medicine industry and have also enshrined patient ethics into the core practice of veterinary medicine. These include monoclonal antibodies and genetically engineered vaccines. The regulation in Japan encourages development of new ideas and products without compromising their safety and effectiveness and that the use of artificial technology in images and treatment is starting to be embraced.

Features of the Global Veterinary Medication Market

Market Size Estimates: Veterinary medication market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Veterinary medication market size by various segments, such as by product, route of administration, distribution channel, animal type, and region in terms of ($B). Regional Analysis: Veterinary medication market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, distribution channels, animal types, and regions for the veterinary medication market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the veterinary medication market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the veterinary medication market size? Answer: The global veterinary medication market is expected to reach an estimated $62.2 billion by 2030. Q.2 What is the growth forecast for veterinary medication market? Answer: The global veterinary medication market is expected to grow with a CAGR of 7.1% from 2024 to 2030. Q.3 What are the major drivers influencing the growth of the veterinary medication market? Answer: The major drivers for this market are growing number of pet ownership, increasing global livestock population, and rising risk of chronic diseases among animals. Q4. What are the major segments for veterinary medication market? Answer: The future of the veterinary medication market looks promising with opportunities in the veterinary hospital pharmacy and retail veterinary pharmacy markets. Q5. Who are the key veterinary medication market companies? Answer: Some of the key veterinary medication companies are as follows:

• Virbac

• Merck

• Archer Daniels Midland

• Dechra Pharmaceuticals

• Ceva Santé Animale

• Boehringer Ingelheim

• Soparfin

• Elanco Animal Health

• Evonik Industries AG

• Zoetis Q6. Which veterinary medication market segment will be the largest in future? Answer: Lucintel forecasts that parenteral will remain the largest segment due to its easy availability and quick onset of action. Q7. In veterinary medication market, which region is expected to be the largest in next 5 years? Answer: North America is expected to witness the highest growth over the forecast period. Q.8 Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.